1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Recombinant Antibody Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Chimeric Antibody 1.2.3 Humanized Antibody 1.2.4 Full Human Antibody 1.2.5 Single Chain Antibody 1.2.6 Bispecific Antibody 1.3 Market by Application 1.3.1 Global Recombinant Antibody Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital 1.3.3 Scientific Research 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Recombinant Antibody Market Perspective (2016-2027) 2.2 Recombinant Antibody Growth Trends by Regions 2.2.1 Recombinant Antibody Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Recombinant Antibody Historic Market Share by Regions (2016-2021) 2.2.3 Recombinant Antibody Forecasted Market Size by Regions (2022-2027) 2.3 Recombinant Antibody Industry Dynamic 2.3.1 Recombinant Antibody Market Trends 2.3.2 Recombinant Antibody Market Drivers 2.3.3 Recombinant Antibody Market Challenges 2.3.4 Recombinant Antibody Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Recombinant Antibody Players by Revenue 3.1.1 Global Top Recombinant Antibody Players by Revenue (2016-2021) 3.1.2 Global Recombinant Antibody Revenue Market Share by Players (2016-2021) 3.2 Global Recombinant Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Recombinant Antibody Revenue 3.4 Global Recombinant Antibody Market Concentration Ratio 3.4.1 Global Recombinant Antibody Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Recombinant Antibody Revenue in 2020 3.5 Recombinant Antibody Key Players Head office and Area Served 3.6 Key Players Recombinant Antibody Product Solution and Service 3.7 Date of Enter into Recombinant Antibody Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Recombinant Antibody Breakdown Data by Type 4.1 Global Recombinant Antibody Historic Market Size by Type (2016-2021) 4.2 Global Recombinant Antibody Forecasted Market Size by Type (2022-2027) 5 Recombinant Antibody Breakdown Data by Application 5.1 Global Recombinant Antibody Historic Market Size by Application (2016-2021) 5.2 Global Recombinant Antibody Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Recombinant Antibody Market Size (2016-2027) 6.2 North America Recombinant Antibody Market Size by Type 6.2.1 North America Recombinant Antibody Market Size by Type (2016-2021) 6.2.2 North America Recombinant Antibody Market Size by Type (2022-2027) 6.2.3 North America Recombinant Antibody Market Size by Type (2016-2027) 6.3 North America Recombinant Antibody Market Size by Application 6.3.1 North America Recombinant Antibody Market Size by Application (2016-2021) 6.3.2 North America Recombinant Antibody Market Size by Application (2022-2027) 6.3.3 North America Recombinant Antibody Market Size by Application (2016-2027) 6.4 North America Recombinant Antibody Market Size by Country 6.4.1 North America Recombinant Antibody Market Size by Country (2016-2021) 6.4.2 North America Recombinant Antibody Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Recombinant Antibody Market Size (2016-2027) 7.2 Europe Recombinant Antibody Market Size by Type 7.2.1 Europe Recombinant Antibody Market Size by Type (2016-2021) 7.2.2 Europe Recombinant Antibody Market Size by Type (2022-2027) 7.2.3 Europe Recombinant Antibody Market Size by Type (2016-2027) 7.3 Europe Recombinant Antibody Market Size by Application 7.3.1 Europe Recombinant Antibody Market Size by Application (2016-2021) 7.3.2 Europe Recombinant Antibody Market Size by Application (2022-2027) 7.3.3 Europe Recombinant Antibody Market Size by Application (2016-2027) 7.4 Europe Recombinant Antibody Market Size by Country 7.4.1 Europe Recombinant Antibody Market Size by Country (2016-2021) 7.4.2 Europe Recombinant Antibody Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Recombinant Antibody Market Size (2016-2027) 8.2 Asia-Pacific Recombinant Antibody Market Size by Type 8.2.1 Asia-Pacific Recombinant Antibody Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Recombinant Antibody Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Recombinant Antibody Market Size by Type (2016-2027) 8.3 Asia-Pacific Recombinant Antibody Market Size by Application 8.3.1 Asia-Pacific Recombinant Antibody Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Recombinant Antibody Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Recombinant Antibody Market Size by Application (2016-2027) 8.4 Asia-Pacific Recombinant Antibody Market Size by Region 8.4.1 Asia-Pacific Recombinant Antibody Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Recombinant Antibody Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Recombinant Antibody Market Size (2016-2027) 9.2 Latin America Recombinant Antibody Market Size by Type 9.2.1 Latin America Recombinant Antibody Market Size by Type (2016-2021) 9.2.2 Latin America Recombinant Antibody Market Size by Type (2022-2027) 9.2.3 Latin America Recombinant Antibody Market Size by Type (2016-2027) 9.3 Latin America Recombinant Antibody Market Size by Application 9.3.1 Latin America Recombinant Antibody Market Size by Application (2016-2021) 9.3.2 Latin America Recombinant Antibody Market Size by Application (2022-2027) 9.3.3 Latin America Recombinant Antibody Market Size by Application (2016-2027) 9.4 Latin America Recombinant Antibody Market Size by Country 9.4.1 Latin America Recombinant Antibody Market Size by Country (2016-2021) 9.4.2 Latin America Recombinant Antibody Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Recombinant Antibody Market Size (2016-2027) 10.2 Middle East & Africa Recombinant Antibody Market Size by Type 10.2.1 Middle East & Africa Recombinant Antibody Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Recombinant Antibody Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Recombinant Antibody Market Size by Type (2016-2027) 10.3 Middle East & Africa Recombinant Antibody Market Size by Application 10.3.1 Middle East & Africa Recombinant Antibody Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Recombinant Antibody Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Recombinant Antibody Market Size by Application (2016-2027) 10.4 Middle East & Africa Recombinant Antibody Market Size by Country 10.4.1 Middle East & Africa Recombinant Antibody Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Recombinant Antibody Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Abnova 11.1.1 Abnova Company Details 11.1.2 Abnova Business Overview 11.1.3 Abnova Recombinant Antibody Introduction 11.1.4 Abnova Revenue in Recombinant Antibody Business (2016-2021) 11.1.5 Abnova Recent Development 11.2 Medix Biochemica 11.2.1 Medix Biochemica Company Details 11.2.2 Medix Biochemica Business Overview 11.2.3 Medix Biochemica Recombinant Antibody Introduction 11.2.4 Medix Biochemica Revenue in Recombinant Antibody Business (2016-2021) 11.2.5 Medix Biochemica Recent Development 11.3 GE Healthcare 11.3.1 GE Healthcare Company Details 11.3.2 GE Healthcare Business Overview 11.3.3 GE Healthcare Recombinant Antibody Introduction 11.3.4 GE Healthcare Revenue in Recombinant Antibody Business (2016-2021) 11.3.5 GE Healthcare Recent Development 11.4 SinoBiological 11.4.1 SinoBiological Company Details 11.4.2 SinoBiological Business Overview 11.4.3 SinoBiological Recombinant Antibody Introduction 11.4.4 SinoBiological Revenue in Recombinant Antibody Business (2016-2021) 11.4.5 SinoBiological Recent Development 11.5 Bioventix 11.5.1 Bioventix Company Details 11.5.2 Bioventix Business Overview 11.5.3 Bioventix Recombinant Antibody Introduction 11.5.4 Bioventix Revenue in Recombinant Antibody Business (2016-2021) 11.5.5 Bioventix Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Recombinant Antibody Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Chimeric Antibody Table 3. Key Players of Humanized Antibody Table 4. Key Players of Full Human Antibody Table 5. Key Players of Single Chain Antibody Table 6. Key Players of Bispecific Antibody Table 7. Global Recombinant Antibody Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Recombinant Antibody Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 9. Global Recombinant Antibody Market Size by Regions (2016-2021) & (US$ Million) Table 10. Global Recombinant Antibody Market Share by Regions (2016-2021) Table 11. Global Recombinant Antibody Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 12. Global Recombinant Antibody Market Share by Regions (2022-2027) Table 13. Recombinant Antibody Market Trends Table 14. Recombinant Antibody Market Drivers Table 15. Recombinant Antibody Market Challenges Table 16. Recombinant Antibody Market Restraints Table 17. Global Recombinant Antibody Revenue by Players (2016-2021) & (US$ Million) Table 18. Global Recombinant Antibody Market Share by Players (2016-2021) Table 19. Global Top Recombinant Antibody Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Antibody as of 2020) Table 20. Ranking of Global Top Recombinant Antibody Companies by Revenue (US$ Million) in 2020 Table 21. Global 5 Largest Players Market Share by Recombinant Antibody Revenue (CR5 and HHI) & (2016-2021) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Recombinant Antibody Product Solution and Service Table 24. Date of Enter into Recombinant Antibody Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Recombinant Antibody Market Size by Type (2016-2021) (US$ Million) Table 27. Global Recombinant Antibody Revenue Market Share by Type (2016-2021) Table 28. Global Recombinant Antibody Forecasted Market Size by Type (2022-2027) (US$ Million) Table 29. Global Recombinant Antibody Revenue Market Share by Type (2022-2027) & (US$ Million) Table 30. Global Recombinant Antibody Market Size Share by Application (2016-2021) & (US$ Million) Table 31. Global Recombinant Antibody Revenue Market Share by Application (2016-2021) Table 32. Global Recombinant Antibody Forecasted Market Size by Application (2022-2027) (US$ Million) Table 33. Global Recombinant Antibody Revenue Market Share by Application (2022-2027) & (US$ Million) Table 34. North America Recombinant Antibody Market Size by Type (2016-2021) (US$ Million) Table 35. North America Recombinant Antibody Market Size by Type (2022-2027) & (US$ Million) Table 36. North America Recombinant Antibody Market Size by Application (2016-2021) (US$ Million) Table 37. North America Recombinant Antibody Market Size by Application (2022-2027) & (US$ Million) Table 38. North America Recombinant Antibody Market Size by Country (2016-2021) & (US$ Million) Table 39. North America Recombinant Antibody Market Size by Country (2022-2027) & (US$ Million) Table 40. Europe Recombinant Antibody Market Size by Type (2016-2021) (US$ Million) Table 41. Europe Recombinant Antibody Market Size by Type (2022-2027) & (US$ Million) Table 42. Europe Recombinant Antibody Market Size by Application (2016-2021) (US$ Million) Table 43. Europe Recombinant Antibody Market Size by Application (2022-2027) & (US$ Million) Table 44. Europe Recombinant Antibody Market Size by Country (2016-2021) & (US$ Million) Table 45. Europe Recombinant Antibody Market Size by Country (2022-2027) & (US$ Million) Table 46. Asia-Pacific Recombinant Antibody Market Size by Type (2016-2021) (US$ Million) Table 47. Asia-Pacific Recombinant Antibody Market Size by Type (2022-2027) & (US$ Million) Table 48. Asia-Pacific Recombinant Antibody Market Size by Application (2016-2021) (US$ Million) Table 49. Asia-Pacific Recombinant Antibody Market Size by Application (2022-2027) & (US$ Million) Table 50. Asia-Pacific Recombinant Antibody Market Size by Region (2016-2021) & (US$ Million) Table 51. Asia-Pacific Recombinant Antibody Market Size by Region (2022-2027) & (US$ Million) Table 52. Latin America Recombinant Antibody Market Size by Type (2016-2021) (US$ Million) Table 53. Latin America Recombinant Antibody Market Size by Type (2022-2027) & (US$ Million) Table 54. Latin America Recombinant Antibody Market Size by Application (2016-2021) (US$ Million) Table 55. Latin America Recombinant Antibody Market Size by Application (2022-2027) & (US$ Million) Table 56. Latin America Recombinant Antibody Market Size by Country (2016-2021) & (US$ Million) Table 57. Latin America Recombinant Antibody Market Size by Country (2022-2027) & (US$ Million) Table 58. Middle East & Africa Recombinant Antibody Market Size by Type (2016-2021) (US$ Million) Table 59. Middle East & Africa Recombinant Antibody Market Size by Type (2022-2027) & (US$ Million) Table 60. Middle East & Africa Recombinant Antibody Market Size by Application (2016-2021) (US$ Million) Table 61. Middle East & Africa Recombinant Antibody Market Size by Application (2022-2027) & (US$ Million) Table 62. Middle East & Africa Recombinant Antibody Market Size by Country (2016-2021) & (US$ Million) Table 63. Middle East & Africa Recombinant Antibody Market Size by Country (2022-2027) & (US$ Million) Table 64. Abnova Company Details Table 65. Abnova Business Overview Table 66. Abnova Recombinant Antibody Product Table 67. Abnova Revenue in Recombinant Antibody Business (2016-2021) & (US$ Million) Table 68. Abnova Recent Development Table 69. Medix Biochemica Company Details Table 70. Medix Biochemica Business Overview Table 71. Medix Biochemica Recombinant Antibody Product Table 72. Medix Biochemica Revenue in Recombinant Antibody Business (2016-2021) & (US$ Million) Table 73. Medix Biochemica Recent Development Table 74. GE Healthcare Company Details Table 75. GE Healthcare Business Overview Table 76. GE Healthcare Recombinant Antibody Product Table 77. GE Healthcare Revenue in Recombinant Antibody Business (2016-2021) & (US$ Million) Table 78. GE Healthcare Recent Development Table 79. SinoBiological Company Details Table 80. SinoBiological Business Overview Table 81. SinoBiological Recombinant Antibody Product Table 82. SinoBiological Revenue in Recombinant Antibody Business (2016-2021) & (US$ Million) Table 83. SinoBiological Recent Development Table 84. Bioventix Company Details Table 85. Bioventix Business Overview Table 86. Bioventix Recombinant Antibody Product Table 87. Bioventix Revenue in Recombinant Antibody Business (2016-2021) & (US$ Million) Table 88. Bioventix Recent Development Table 89. Research Programs/Design for This Report Table 90. Key Data Information from Secondary Sources Table 91. Key Data Information from Primary Sources List of Figures Figure 1. Global Recombinant Antibody Market Share by Type: 2020 VS 2027 Figure 2. Chimeric Antibody Features Figure 3. Humanized Antibody Features Figure 4. Full Human Antibody Features Figure 5. Single Chain Antibody Features Figure 6. Bispecific Antibody Features Figure 7. Global Recombinant Antibody Market Share by Application: 2020 VS 2027 Figure 8. Hospital Case Studies Figure 9. Scientific Research Case Studies Figure 10. Others Case Studies Figure 11. Recombinant Antibody Report Years Considered Figure 12. Global Recombinant Antibody Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 13. Global Recombinant Antibody Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 14. Global Recombinant Antibody Market Share by Regions: 2020 VS 2027 Figure 15. Global Recombinant Antibody Market Share by Regions (2022-2027) Figure 16. Global Recombinant Antibody Market Share by Players in 2020 Figure 17. Global Top Recombinant Antibody Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Antibody as of 2020 Figure 18. The Top 10 and 5 Players Market Share by Recombinant Antibody Revenue in 2020 Figure 19. Global Recombinant Antibody Revenue Market Share by Type (2016-2021) Figure 20. Global Recombinant Antibody Revenue Market Share by Type (2022-2027) Figure 21. North America Recombinant Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 22. North America Recombinant Antibody Market Share by Type (2016-2027) Figure 23. North America Recombinant Antibody Market Share by Application (2016-2027) Figure 24. North America Recombinant Antibody Market Share by Country (2016-2027) Figure 25. United States Recombinant Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Canada Recombinant Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Recombinant Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Europe Recombinant Antibody Market Share by Type (2016-2027) Figure 29. Europe Recombinant Antibody Market Share by Application (2016-2027) Figure 30. Europe Recombinant Antibody Market Share by Country (2016-2027) Figure 31. Germany Recombinant Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. France Recombinant Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. U.K. Recombinant Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Italy Recombinant Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Russia Recombinant Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Nordic Recombinant Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Recombinant Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Asia-Pacific Recombinant Antibody Market Share by Type (2016-2027) Figure 39. Asia-Pacific Recombinant Antibody Market Share by Application (2016-2027) Figure 40. Asia-Pacific Recombinant Antibody Market Share by Region (2016-2027) Figure 41. China Recombinant Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Japan Recombinant Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. South Korea Recombinant Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Southeast Asia Recombinant Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. India Recombinant Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Australia Recombinant Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Recombinant Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Latin America Recombinant Antibody Market Share by Type (2016-2027) Figure 49. Latin America Recombinant Antibody Market Share by Application (2016-2027) Figure 50. Latin America Recombinant Antibody Market Share by Country (2016-2027) Figure 51. Mexico Recombinant Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Brazil Recombinant Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Recombinant Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Middle East & Africa Recombinant Antibody Market Share by Type (2016-2027) Figure 55. Middle East & Africa Recombinant Antibody Market Share by Application (2016-2027) Figure 56. Middle East & Africa Recombinant Antibody Market Share by Country (2016-2027) Figure 57. Turkey Recombinant Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Saudi Arabia Recombinant Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. UAE Recombinant Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. Abnova Revenue Growth Rate in Recombinant Antibody Business (2016-2021) Figure 61. Medix Biochemica Revenue Growth Rate in Recombinant Antibody Business (2016-2021) Figure 62. GE Healthcare Revenue Growth Rate in Recombinant Antibody Business (2016-2021) Figure 63. SinoBiological Revenue Growth Rate in Recombinant Antibody Business (2016-2021) Figure 64. Bioventix Revenue Growth Rate in Recombinant Antibody Business (2016-2021) Figure 65. Bottom-up and Top-down Approaches for This Report Figure 66. Data Triangulation Figure 67. Key Executives Interviewed

Abnova Medix Biochemica GE Healthcare SinoBiological Bioventix